ZEKEYA LOFTON: Open Payments
NPI 1578582987 · SUNNYVALE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,876 in 139 payments from 30 companies in 2025. Trend: 2023 $324 · 2024 $3,921 · 2025 $2,876
Food & beverage: $2,864Education: $12
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $303 |
| Bayer Healthcare Pharmaceuticals Inc. | 18 | $294 |
| Xeris Pharmaceuticals, Inc. | 15 | $275 |
| Medtronic, Inc. | 8 | $250 |
| Corcept Therapeutics | 12 | $226 |
| Lilly USA, LLC | 9 | $164 |
| Sequel Med Tech, LLC | 8 | $149 |
| Tandem Diabetes Care, Inc. | 4 | $112 |
| Verity Pharmaceuticals Inc. | 4 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $93 |
Products named: Kerendia, MINIMED 780G, Korlym, RECORLEV, Ozempic, TWIIST, JARDIANCE, MOUNJARO.
Industry payments across TX — which companies pay providers there.
